SCHEMBL691387

SCHEMBL691387

CC1=CC(C)OC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12038674 1.00
SCHEMBL12038700 1.00
SCHEMBL12713998 0.75 NFE2L2 (0.37)
SCHEMBL15058421 0.72
SCHEMBL3485633 0.72
SCHEMBL16093273 0.72
SCHEMBL14731971 0.72
SCHEMBL7548600 0.72
SCHEMBL22355992 0.72
SCHEMBL17131084 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107484766-A Agricultural chemicals and preparation, application process based on natural cumarin essential oil in common fig leaf juice 郑州市汇川农业科技有限公司 2017-12-19 CN claimed
CN-118680318-A Method for preparing heated cigarette slices by pretreating tobacco leaves through slow pyrolysis 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) 2024-09-24 CN disclosed
US-11771864-B2 Devices, systems and methods for delivering coffee-derived volatiles Jorge Neval Moll Neto 2023-10-03 US disclosed
EP-3519026-B1 DEVICE FOR DELIVERING COFFEE-DERIVED VOLATILES MOLL NETO JORGE NEVAL (US) 2022-12-07 EP disclosed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-11148125-B2 Catalysts for olefin isomerization BRANDEIS UNIVERSITY (US) 2021-10-19 US disclosed
CN-113167695-A Device for collecting volatile organic compounds 法国由内政部代表 2021-07-23 CN disclosed
EP-3030098-B1 TOBACCO-DERIVED PYROLYSIS OIL REYNOLDS TOBACCO CO R (US) 2021-01-06 EP disclosed
US-20200269009-A1 DEVICES, SYSTEMS AND METHODS FOR DELIVERING COFFEE-DERIVED VOLATILES Jorge Neval Moll Neto 2020-08-27 US disclosed
EP-3686201-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2020-07-29 EP disclosed
US-20110015436-A1 METHOD FOR PRODUCING BETA-MERCAPTO CARBOXYLIC ACIDS SHOWA DENKO K.K. (JP) 2011-01-20 US disclosed
US-20110014504-A1 LITHIUM SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2011-01-20 US disclosed
US-20110004017-A1 METHOD FOR PRODUCING B-MERCAPTOCARBOXYLIC ACIDS SHOWA DENKO K.K. (JP) 2011-01-06 US disclosed
US-20100120905-A1 SYSTEM AND METHOD FOR CONTROLLING GROWTH OF MICROORGANISMS WITH BROMINATED FURANONES SYRACUSE UNIVERSITY (US) 2010-05-13 US disclosed
US-7645781-B2 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives PFIZER INC (US) 2010-01-12 US disclosed
EP-1709044-B1 OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS MORPHOCHEM AG KOMB CHEMIE (DE) 2008-07-16 EP disclosed
US-20080090884-A1 ANTIMICROBIAL [3.1.0] BICYCLOHEXYLPHENYL- OXAZOLIDINONE DERIVATIVES AND ANALOGUES PFIZER INC 2008-04-17 US disclosed
US-7322965-B2 Infection-resistant medical devices PHARMACIA & UPJOHN COMPANY (US) 2008-01-29 US disclosed
US-7279494-B2 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues PFIZER INC. (US) 2007-10-09 US disclosed
US-20070015801-A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives THOMAS RICHARD C 2007-01-18 US disclosed